Li, X., Li, X., Chen, S., Chen, S., Shi, Y., Wang, Y., . . . Ma, L. Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Xue, et al. Transcription Factor MEF2D Regulates Aberrant Expression of ACSL3 and Enhances Sorafenib Resistance by Inhibiting Ferroptosis in HCC. Frontiers Media S.A.
MLA (9th ed.) CitationLi, Xue, et al. Transcription Factor MEF2D Regulates Aberrant Expression of ACSL3 and Enhances Sorafenib Resistance by Inhibiting Ferroptosis in HCC. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.